The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

SOLUTIONS with/in/sight: Pushing Boundaries, Breaking Barriers in Brain Cancer

Wednesday, April 15, 2020

Members of the Koch Institute’s Hammond lab, Yaffe lab, and Clinical Investigators Program are combining nanotechnology and novel drug combinations to treat glioblastoma. Professor Paula Hammond describes how the team’s Trojan horse approach sneaks across the blood brain barrier and packs a one-two punch that hits cancer cells while their defenses are down. Dr. Fred Lam, who contributed to this work during his time at MIT, offers perspective on the implications of this new strategy for improving patient care. Moderated by Professor Michael Yaffe, this program presents a powerful picture of how diverse perspectives can reshape the way we think about and overcome biomedical challenges.


Paula Hammond, PhD
Head, MIT Department of Chemical Engineering
David H. Koch Professor in Engineering
Member, Marble Center for Cancer Nanomedicine

Fred C. Lam, MD, PhD
Clinical Scholar, Division of Neurosurgery, McMaster University, Ontario, Canada
Research Scientist, Koch Institute

Moderated by Michael B. Yaffe, MD, PhD
Director, Koch Institute Clinical Investigator Program
Director, MIT Center for Precision Cancer Medicine
David H. Koch Professor of Science
Professor of Biology and Biological Engineering

Details and registration info forthcoming